Effective medical education solutions for HCPs and patients

Experience expert–curated hubs and patient programs – created, updated, and endorsed by expert steering committees and medical societies for medical and healthcare professionals, patients, and caregivers.

Our hubs

SES hubs allow time-stretched healthcare professionals to easily access curated scientific, medical, and clinical information that expedites their learning and empowers their treatment decisions. Informed by patients, curated by world leaders, and endorsed by expert societies, our hubs support healthcare professionals worldwide.

Information overload solved

In lymphoma alone, around 15,000 clinical papers were published in 2023, which equates to nearly 40 papers a day or 2 every hour! This, combined with the complexity of diseases and the disparate nature of where the data/information is located, has resulted in the opportunity to support community healthcare professionals by providing everything related to a disease in one place: Our hubs.

Helping increase knowledge of upcoming therapeutics

We curate a continual flow of news and updates, allowing swift integration into clinical practice, so HCPs are best placed to support their patients.

Endorsed by expert societies

We work closely with expert societies and world opinion leaders, ensuring credibility and trust in the quality of our content, thus increasing the chance of time-limited HCPs engaging with our content.

Reaching over 6 million HCPs annually

Our educational platforms have a wide global reach, have an average satisfaction score of 4.6/5, and improve the knowledge of 39% of HCPs who engage with our content.

Designed to solve educational needs

Knowledge gaps are identified by our expert steering committee and patients, so we can ensure our content supports HCPs in improving patient outcomes.

Curating content designed to be digested in minutes

We support time-poor HCPs to expedite their learning, delivered in impactful, easily digestible micro-learning formats.

Acute lymphoblastic leukemia (ALL)

Acute myeloid leukemia (AML)

Graft-versus-host disease (GvHD)

Lymphoma and chronic lymphocytic leukemia (CLL)


Multiple myeloma

Myeloproliferative neoplasms (MPN)

Psoriasis and psoriatic arthritis (PsOPsA)

Co-chaired by

Charles Mullighan St. Jude Children’s Research Hospital, Memphis, USHervé Dombret Université de Paris, Paris, FRFranco Locatelli Bambino Gesù Children’s Hospital, Rome, IT

Charles Mullighan

St. Jude Children’s Research Hospital, Memphis, US

Hervé Dombret

Université de Paris, Paris, FR

Franco Locatelli

Bambino Gesù Children’s Hospital, Rome, IT

An open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education on acute lymphoblastic leukemia (ALL)

In partnership with

The European School of Haematology (ESH)

The European School of Haematology (ESH)

Commitment to IME integrity and standards

Scientific Education Support (SES) is a member of the Good CME Practice Group, which means that all Independent Medical Education (IME) and Continuing Medical Education (CME) materials created for the hubs provide a fair and balanced overview, free from bias with no influence from the financial supporters.

Our patient programs

Our patient programs aim to provide patients and carers with a voice, so they can share their experiences and challenges. We collaborate very closely with our patient societies to ensure our work is effective at delivering disease and treatment awareness for patients and carers worldwide.

Putting patients first

Patients are so often overlooked as partners within the treatment team. Our strategy and tactics are guided by what patients tell us. Our regular global campaigns engage with communities to increase understanding, help people to recognize symptoms early, and empower them to become partners in their own care.

Collaboration at the heart

We work with those who support patients in achieving a better experience of the health service and an improved quality of life.

Driven by science

Our programs are supported by the latest scientific research to ensure they provide effective solutions.

Disseminated across the world

Over 50 patient societies work with us to reach a truly global audience.

Acute myeloid leukemia (AML)

Acute lymphoblastic leukemia (ALL)

International Waldenstrom's Macroglobulinemia Foundation (IWMF)

Chaired by

Ralph Hills Patient, USA

Ralph Hills

Patient, USA

Know AML is the first global education and awareness initiative that provides patients and caregivers with the information, resources, and support they need to deal with acute myeloid leukemia

In partnership with

Acute Leukemia Advocates Network (ALAN)

Acute Leukemia Advocates Network (ALAN)